News Karnataka
Wednesday, December 06 2023

Canberra: Aus govt pledges funding for long Covid research

Majority of Australian students' education affected by Covid pandemic: Survey
Photo Credit : IANS

Canberra: The Australian government has committed new funding for research into long Covid, Health Minister Mark Butler announced on Monday.

Butler announced that A$50 million ($33 million) from the Medical Research Future Fund will be made available for research into post-acute sequelae of Covid-19 (PASC), reports Xinhua news agency.

Butler said the funding would help improve the knowledge of PASC, commonly known as long Covid, and provide evidence to inform policy and health responses.

The announcement was made to coincide with the release of a parliamentary report into the health, economic and social impacts of long Covid.

The standing committee on health, aged care and sport called for the establishment of a single national Covid-19 database under the Australian Centre for Disease Control and a nationally-coordinated research program into Covid-19 and long Covid.

“Long Covid is an emerging health issue, both in Australia and internationally,” Butler said in a statement.

“I have tasked my department with developing a national plan to respond to long Covid, taking into consideration the committee’s findings.”

The World Health Organization defines long Covid as the continuation or development of new symptoms three months after the initial infection, with these symptoms lasting for at least two months with no other explanation.

Monday’s report said Australia should continue to use that definition for the time being but work on reviewing it as research becomes available.

Mike Freelander, the chair of the committee, said the inquiry was hampered by a lack of specific data on long Covid in Australia.

“It is clear that long Covidis a significant problem and estimates vary, indicating that between 2 per cent to 20 per cent of those infected with Covid-19 may develop long Covid,” he wrote.

“At this stage it does seem that specific treatments require more evidence of benefit before being specifically recommended, but this will become clearer over time.”

Share this:
Support NewsKarnataka's quality independent journalism with a small contribution.

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Editor's Pick

Find the best odds at 10Cric and IPL Betting 2023! Signup today and get up to a 100% deposit bonus.

To get the latest news on WhatsApp